Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DCL000583

Drug Information
Synonyms4-[(3-{[4-Cyclopropylcarbonyl)piperazin-4-yl]carbonyl}-4-fluorophenyl)methyl]phtalazin-1(2H)-one; 937799-91-2; AZD2281; KU-0059436; AKOS005145764; Olaparib, KU-0059436, AZD2281, KU0059436, AZD2281; S1060_Selleck; Olaparib; AZD-2281; AZD 2281; EC-000.2324; CHEMBL521686; EN002690; KU-59436; 4-[3-(4-Cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one; 763113-22-0; FT-0083489; Acylpiperazine analogue, 47
IndicationBreast/ovarian cancer
[ICD9: 174, 175, 183   ICD10: C50, C56]
Phase II    

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Canonical SMILESC1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F    
CAS NumberCAS 763113-22-0
PubChem Compound IDCID 23725625.
PubChem Substance IDSID 47209066.
TargetPoly [ADP-ribose] polymerase 1Inhibitor[1]
Ref 1AstraZeneca. Product Development Pipeline. January 29 2009. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543